Back to Results

Implementing a pharmacist-led protocol to survey and follow-up people living with HIV taking Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) single tablet regimen after being switched from two tablet regimen of Dolutegravir plus Emtricitabine/Tenofovir Alafenamide (DTG + FTC/TAF): patients' satisfaction and adherence

Study category: Immune System and Allergy

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Other

Locations

University of Colorado Hospital

Study ID

Protocol Number: 18-0715

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers